Pilot study data submission as pivotal study [Off Topic]

posted by dshah  – India, 2023-10-03 18:30 (584 d 15:44 ago) – Posting: # 23733
Views: 2,350

Dear QA!

❝ If pilot study passes the bio-equivalence criteria with 12 evaluable subjects, can it be submitted to the regulatory authority instead of conducting another pivotal study based on ethical reason and to avoid any unnecessary exposure of drug to healthy human subjects?


If your batch size/scale remains same, was manufactured under cGMP condition, it could be used.

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
97 visitors (0 registered, 97 guests [including 6 identified bots]).
Forum time: 10:15 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5